Margo Brooks-Carthon, PhD, has been named the Tyson Family Endowed Term Chair for Gerontological Research; and Heath Schmidt, PhD, has been named the Killebrew-Censits Chair in Undergraduate Education. Both appointments are effective July 1, 2021.
It’s an ethical question that experts like Alison Buttenheim of the School of Nursing, Harald Schmidt of the Perelman School of Medicine, and Kok-Chor Tan of the School of Arts & Sciences are contemplating. One fact is certain, they say: Distribution must not exacerbate persisting disparities.
Opioid use disorder and overdose deaths are a major public health crisis in the United States. While medication-assisted treatments for opioid use disorder exist, these treatments remain inadequate for many patients, resulting in a high rate of relapse following detoxification.
There are ways you could try to quantify the reach and influence of Penn Nursing. You could look at school rankings, which for the past five years have placed the School in the number one spot in the world. Or you could calculate the amount of research funding it’s been awarded by the National Institutes of Health.
All the honorees will be recognized during a virtual, end-of-the-year event that is being planned. Details on that to come.
Cocaine continues to be one of the most commonly abused illicit drugs in the United States. Pre-clinical literature suggests that targeting glucagon-like peptide-1 receptors (GLP-1Rs) in the brain may represent a novel approach to treating cocaine use disorder. Specifically, GLP-1R agonists, which are FDA-approved for treating diabetes and obesity, have been shown to reduce voluntary drug taking and seeking in preclinical models of cocaine use disorder. However, the exact neural circuits and cell types that mediate the suppressive effects of GLP-1R agonists on cocaine-seeking behavior are mostly unknown.